[Clinical trial with naproxen, with particular consideration to tolerance].
D000284:Administration, Oral; D000328:Adult; D001172:Arthritis, Rheumatoid / Q000188:drug therapy; D002986:Clinical Trials as Topic; D004341:Drug Evaluation; D004361:Drug Tolerance; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007677:Kidney Function Tests; D008111:Liver Function Tests; D008297:Male; D008738:Methyl Ethers / Q000009:adverse effects / Q000627:therapeutic use; D009281:Naphthalenes / Q000009:adverse effects / Q000627:therapeutic use; D009437:Neuralgia / Q000188:drug therapy; D010003:Osteoarthritis / Q000188:drug therapy; D011422:Propionates / Q000009:adverse effects / Q000627:therapeutic use*; D012216:Rheumatic Diseases / Q000188:drug therapy*; D000637:Transaminases / Q000097:blood
D008738:Methyl Ethers; D009281:Naphthalenes; D011422:Propionates; D000637:Transaminases
Klinische Untersuchung von Naproxen, vor allem mit Bezug auf seine Verträglichkeit.